Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
作者信息
Lichtenstein Gary R, Rubin David T
机构信息
Division of Gastroenterology, Department of Medicine, The Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
出版信息
Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
Abstract
摘要
相似文献
1
Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.冠状病毒与炎症性肠病患者：临床医生的管理策略
Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
2
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.美国胃肠病学会关于2019冠状病毒病大流行期间炎症性肠病管理的临床实践更新：专家评论
Gastroenterology. 2020 Jul;159(1):350-357. doi: 10.1053/j.gastro.2020.04.012. Epub 2020 Apr 10.
3
Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.意大利北部严重急性呼吸综合征冠状病毒2疫情期间炎症性肠病患者的平稳病程
Gastroenterology. 2020 Jul;159(1):371-372. doi: 10.1053/j.gastro.2020.03.062. Epub 2020 Apr 2.
4
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.米兰 Humanitas 医院 IBD 门诊的 COVID-19 感染零病例：对解封后措施的启示。
Am J Gastroenterol. 2020 Oct;115(10):1719-1721. doi: 10.14309/ajg.0000000000000829.
5
Hematopoietic stem cell transplantation dilemma during the COVID-19 era.新冠疫情时代造血干细胞移植的困境
Future Oncol. 2020 Aug;16(22):1569-1573. doi: 10.2217/fon-2020-0414. Epub 2020 May 27.
6
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.
7
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.COVID-19 期间停用免疫抑制剂药物的炎症性肠病患者重启治疗的指导意见。
J Crohns Colitis. 2020 Oct 21;14(14 Suppl 3):S769-S773. doi: 10.1093/ecco-jcc/jjaa135.
8
ICI Impact on COVID-19 Severity Modest at Best.ICI 对 COVID-19 严重程度的影响充其量只是适度的。
Cancer Discov. 2020 Oct;10(10):1432-1433. doi: 10.1158/2159-8290.CD-NB2020-079. Epub 2020 Aug 19.
9
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy.美国胃肠病学会关于术前新型冠状病毒2检测与内镜检查作用的快速回顾及建议
Gastroenterology. 2020 Nov;159(5):1935-1948.e5. doi: 10.1053/j.gastro.2020.07.043. Epub 2020 Jul 28.
10
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.炎症性肠病患者 COVID-19 的流行病学及治疗对结局的影响。
Am J Gastroenterol. 2020 Oct;115(10):1722-1724. doi: 10.14309/ajg.0000000000000830.
引用本文的文献
1
Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management.炎症性肠病：临床诊断与药物治疗
Med Res Arch. 2023 Jan;11(1). doi: 10.18103/mra.v11i1.3135. Epub 2023 Jan 31.
2
Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.炎症性肠病：临床诊断与外科治疗概述。
Medicina (Kaunas). 2022 Apr 21;58(5):567. doi: 10.3390/medicina58050567.
3
Highlights From the 2021 Advances in Inflammatory Bowel Diseases Conference: Commentary.2021年炎症性肠病会议亮点：评论
Gastroenterol Hepatol (N Y). 2021 Dec;17(12 Suppl 7):14-19.
4
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.跨膜丝氨酸蛋白酶 2 和血管紧张素转换酶 2 抗炎受体治疗 COVID-19/炎症性肠病。
World J Gastroenterol. 2021 Dec 14;27(46):7943-7955. doi: 10.3748/wjg.v27.i46.7943.
5
Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.SARS-COV-2 感染背景下炎症性肠病的发病机制。
Mol Biol Rep. 2021 Jul;48(7):5745-5758. doi: 10.1007/s11033-021-06565-w. Epub 2021 Jul 22.
6
Management of IBD Patients During the COVID-19 Pandemic.
Gastroenterol Hepatol (N Y). 2020 Nov;16(11):577-580.
7
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.在 COVID-19 大流行期间如何管理炎症性肠病：临床医生实用指南。
World J Gastroenterol. 2021 Mar 21;27(11):1022-1042. doi: 10.3748/wjg.v27.i11.1022.
本文引用的文献
1
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.皮质类固醇，而不是 TNF 拮抗剂，与炎症性肠病患者 COVID-19 不良结局相关：来自国际登记处的结果。
Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18.
2
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
3
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
4
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.免疫介导性炎症疾病中的新冠病毒病——来自纽约的病例系列
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
5
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.轻度疾病严重程度的 COVID-19 患者的消化症状：临床表型、粪便病毒 RNA 检测和结局。
Am J Gastroenterol. 2020 Jun;115(6):916-923. doi: 10.14309/ajg.0000000000000664.
6
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.2019冠状病毒病大流行期间克罗恩病和溃疡性结肠炎患者的管理：一次国际会议的结果
Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6.
7
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.香港队列粪便样本中 SARS-CoV-2 感染的胃肠道表现及病毒载量：系统评价与荟萃分析
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
8
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
9
COVID-19: combining antiviral and anti-inflammatory treatments.2019冠状病毒病：联合抗病毒与抗炎治疗
Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件